Novavax, Inc.
NASDAQ:NVAX
Market Cap (Intraday) | 1.11B |
Current PE | 2.31 |
Forward PE | 2.79 |
2yr Forward PE | 29.57 |
10-Day MA | N/A |
50-Day MA | N/A |
200-Day MA | N/A |
Novavax, Inc. Stock, NASDAQ:NVAX
700 Quince Orchard Road, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.268.2000
Number of Employees: 952
Description
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.